Micromanaging restenosis by therapeutic inhibition of miR-92a

Cardiovasc Res. 2014 Sep 1;103(4):432-4. doi: 10.1093/cvr/cvu178. Epub 2014 Jul 31.

Authors

Mario Leonardo Squadrito¹, Michele De Palma²

Affiliations

¹ Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland.
² Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne 1015, Switzerland michele.depalma@epfl.ch.

PMID: 25082845
DOI: 10.1093/cvr/cvu178

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Endothelial Cells / metabolism*
Humans
MicroRNAs / genetics*
Neointima / genetics*
Neovascularization, Pathologic / genetics*
Vascular System Injuries / genetics*

Substances

MIRN92 microRNA, human
MicroRNAs
Mirn92 microRNA, mouse